Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2009
08/13/2009CA2714480A1 3,8-diaminotetrahydroquinoline derivative
08/13/2009CA2714232A1 Pyridinyl amides for the treatment of cns and metabolic disorders
08/13/2009CA2714181A1 Ampk modulators
08/13/2009CA2713519A1 Amide derivatives as positive allosteric modulators and methods of use thereof
08/13/2009CA2713347A1 Mesoionic pesticides
08/13/2009CA2712582A1 Aryl sulfonamides as effective analgesics
08/13/2009CA2711399A1 3-substituted sulfonylpiperidine derivative
08/13/2009CA2710462A1 Novel pyridinones and pyridazinones
08/12/2009EP2088146A2 Polymorphs of 3-[(2-{[4-(hexyloxy carbonyl amino-imino-methyl)-phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propion acid-ethyl ester
08/12/2009EP2088141A2 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same
08/12/2009EP2087891A2 Pharmaceutical compositions for treating lymphoma
08/12/2009EP2086983A2 Fused ring compounds for inflammation and immune-related uses
08/12/2009EP2086964A2 Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through glk
08/12/2009EP2086963A2 Hepatitis c virus inhibitors
08/12/2009EP2086962A1 (r) -5-methyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylic acid 1- [( 4 -chlorophenyl) amide 5-{ [2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phenyl]amide) as a factor xa inhibitor
08/12/2009EP2086961A1 Heterocyclic derivatives as cetp inhibitors
08/12/2009EP2086960A1 Novel inhibitors of glutaminyl cyclase
08/12/2009EP2086959A1 Substituted 2-imidazoles as modulators of the trace amine associated receptors
08/12/2009EP2086958A2 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
08/12/2009EP2086947A1 Pyrimidines and their use as cxcr2 receptor antagonists
08/12/2009EP2086942A2 Novel compounds
08/12/2009EP2086939A2 Pyridine carboxamides as 11-beta-hsd1 inhibitors
08/12/2009EP2086938A1 Organic compounds
08/12/2009EP2086935A1 Substituted sulfonamide derivatives for use as bradykinin 1 receptor modulators
08/12/2009EP2086326A2 Cyclohexenyl-aryl compounds for inflammation and immune-related uses
08/12/2009EP1904461B1 Cyclic anilino-pyridinotriazines as gsk-3 inhibitors
08/12/2009EP1885695B8 Indoline compounds
08/12/2009EP1789395B8 Method for chiral inversion of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof
08/12/2009EP1756096B1 Indolyl derivatives as liver-x-receptor modulators
08/12/2009EP1682121B1 Use of crth2 antagonist compounds in therapy
08/12/2009EP1636221B1 3-Heterocyclyl-Azetidine compounds useful as NK1/NK2 receptors antagonists
08/12/2009EP1461384B1 Novel flame retarding compounds
08/12/2009EP1427415B1 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
08/12/2009EP1343760B1 Muscarinic antagonists
08/12/2009EP1224170B1 6-position substituted indoline, production and use thereof as a medicament
08/12/2009EP1077941B1 Compounds with growth hormone releasing properties
08/12/2009EP0788360B3 Boronic ester and acid compounds, synthesis and uses
08/12/2009CN201288157Y Apparatus for refining omeprazole
08/12/2009CN101506202A mGluR5 modulators I
08/12/2009CN101506197A Compound having triazine ring structure substituted with pyridyl group and organic electroluminescent device
08/12/2009CN101506196A Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses
08/12/2009CN101506195A New pyridone derivatives with MCH antagonistic activity and medicaments comprising these compounds
08/12/2009CN101506194A New pyridine analogues
08/12/2009CN101506193A New pyridine analogues
08/12/2009CN101506176A 2-anilino-4-aminoalkyleneaminopyrimidines
08/12/2009CN101506175A 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase C-alpha
08/12/2009CN101506171A Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
08/12/2009CN101506170A 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as HIV integrase inhibitor
08/12/2009CN101506165A Phenyl, pyridine and quinoline derivatives
08/12/2009CN101506164A Piperidine derivatives
08/12/2009CN101506162A Substituted isoindoles as bace inhibitors and their use
08/12/2009CN101503403A Preparation of sulfonylurea herbicide nicosulfuron
08/12/2009CN101503402A 2-aniline pyrimidine derivative, as well as preparation and uses thereof
08/12/2009CN101503393A Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same
08/12/2009CN101503392A Aromatic aminomethane compounds, as well as preparation and medical use thereof
08/12/2009CN100526308C Arylvinylazacycloalkane compounds and methods of preparation and use thereof
08/12/2009CN100526307C Metalloproteinase inhibitors
08/12/2009CN100526298C Amide derivative and medicine
08/12/2009CN100525766C (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
08/12/2009CN100525763C Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
08/11/2009US7572924 Pyrrole substituted 2-indolinone protein kinase inhibitors
08/11/2009US7572922 Substituted pyrazoles, compositions containing such compounds and methods of use
08/11/2009US7572921 Substituted benzylimidazoles useful for the treatment of inflammatory diseases
08/11/2009US7572919 Heteroaryl-containing isoflavones as aromatase inhibitors
08/11/2009US7572916 For the preparation of (R)-(+)-6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl) methyl]-4-(3-chlorophenyl)-1-methyl2(1H)-quinolinone; farnesyl tranferase inhibitory activity
08/11/2009US7572915 Quinoline derivatives as phosphodiesterase inhibitors
08/11/2009US7572914 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease
08/11/2009US7572913 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine
08/11/2009US7572911 Azotization of 5-amino-3-t-butyl-4-cyanopyrazole, then reacting with couplers and alkylation or arylation, to form azo dyes, used as inks having colorfastness; liquid crystal displays and plasma display panels; excellent color reproducibility
08/11/2009US7572830 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
08/11/2009US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid
08/11/2009US7572816 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
08/11/2009US7572815 Amide derivative
08/11/2009US7572812 Treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis
08/11/2009US7572806 PPAR active compounds
08/11/2009US7572798 Combi-molecules having signal transduction inhibitory properties and DNA damaging properties
08/11/2009US7572796 excitatory amino acid antagonists for treating neurodegenerative diseases as cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, cerebral ischaemia, infarction, psychoses; 6-{3-[4-(4-fluorobenzyl)-1-piperidyl]propyl}-1H-indole-3-carbonitrile
08/11/2009US7572793 Tau protein kinase 1 inhibitors; treatment for neurodegenerative disorders; Alzheimer's Disease, Parkinson's disease, Pick's Disease, vision defects; antiischemic, antidiabetic, anticarcinogenic, antitumor agents, antidepressants
08/11/2009US7572792 2,4-dichloro-N-{[1- (propylsulfonyl)-3-pyridin-2- ylazetidin-3- yl]methyl}benzamide; neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction
08/11/2009US7572788 Compositions and methods relating to novel compounds and targets thereof
08/11/2009US7572786 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
08/11/2009CA2537410C Ophthalmic indazole comprising compositions for treating ocular hypertension
08/11/2009CA2527933C Substituted 3-alkyl and 3-alkenyl azetidine derivatives
08/11/2009CA2482551C 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
08/11/2009CA2449402C Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases
08/11/2009CA2395846C Diazepan derivatives or salts thereof
08/11/2009CA2222552C N-oxides as antibacterial agents
08/11/2009CA2219359C Hydantoin derivatives as intermediates for pharmaceutical active compounds
08/11/2009CA2174060C Inhibition of unsaturated monomers with 7-aryl quinone methides
08/06/2009WO2009097306A1 Substituted pyridazine derivatives which have histamine h3 antagonist activity
08/06/2009WO2009096941A1 Substituted heterocyclic ethers and their use in cns disorders
08/06/2009WO2009096905A1 Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds
08/06/2009WO2009096786A1 Novel phenol compounds and (co)polymers thereof
08/06/2009WO2009096526A1 Carboxylic acid compound or salt thereof
08/06/2009WO2009095872A2 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
08/06/2009WO2009095773A2 Novel heterocycles
08/06/2009WO2009095438A1 Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptors
08/06/2009WO2009095399A2 Pyrazine derivatives and their use as protein kinase inhbitors
08/06/2009WO2009095394A1 Diazepanes as histamine h3 receptor antagonists
08/06/2009WO2009095163A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals